Assignee
ONCOLMMUNE INC
US·3 granted patents·5 pending applications·4 citations·filing 2013–2021
Top patents by PatentIndex Score
8 records- 0185US10369197B2Use of CD24 for lowering low-density lipoprotein cholesterol levelsONCOLMMUNE INC·Filed 2016·Granted Aug 6, 2019·3 cites·21 claims
- 0280US11026995B2Use of CD24 for lowering low-density lipoprotein cholesterol levelsONCOLMMUNE INC·Filed 2019·Granted Jun 8, 2021·1 cites·16 claims
- 0363US2022098278A1Methods of Use of Soluble CD24 for Neuroprotection and RemyelinationONCOLMMUNE INC·Filed 2021·Application pending·0 cites
- 0462US2013231464A1Methods of use of soluble cd24 for therapy of rheumatoid arthritisONCOLMMUNE INC·Filed 2013·Application pending·0 cites
- 0560US9623070B2Uses of hypoxia-inducible factor inhibitorsONCOLMMUNE INC·Filed 2016·Granted Apr 18, 2017·0 cites·6 claims
- 0646US2022000974A1Targeting CD24-Siglec Interactions for Treating Subjects with Prediabetes or DiabetesONCOLMMUNE INC·Filed 2020·Application pending·0 cites
- 0745US2022000973A1Targeting CD24-Siglec Interactions for the Treatment and Prevention of Nonalcoholic SteatohepatitisONCOLMMUNE INC·Filed 2020·Application pending·0 cites
- 0845US2021047410A1Methods of selecting and designing safer and more effective anti-ctla-4 antibodies for cancer therapyONCOLMMUNE INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →